Vanda Pharmaceuticals (VNDA) Return on Sales (2010 - 2026)

Vanda Pharmaceuticals' Return on Sales history runs 17 years deep, the most recent figure standing at 0.01% for Q1 2026.

• In Q1 2026, Return on Sales changed 0.0% year-over-year to 0.01%; the TTM figure through Mar 2026 stood at 0.01% (down 1.0% YoY), while the FY2025 annual figure was 0.01%, down 1.0% from the prior year.
• Return on Sales came in at 0.01% for Q1 2026 at Vanda Pharmaceuticals, up from 0.02% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.0% in Q4 2022 to a low of 0.02% in Q4 2025.
• A 5-year average of 0.0% and a median of 0.0% in 2024 frame the typical range for Return on Sales.
• Across the five-year window, Return on Sales changed 0 bps in 2022 and dropped 2 bps in 2025, its largest moves.
• Vanda Pharmaceuticals' Return on Sales stood at 0.0% in 2022, then tumbled by 150 bps to 0.0% in 2023, then slumped by 74 bps to 0.0% in 2024, then slumped by 2592 bps to 0.02% in 2025, then surged by 62 bps to 0.01% in 2026.
• According to Business Quant data, Return on Sales over the past three periods registered 0.01%, 0.02%, and 0.0% for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison